首站-论文投稿智能助手
典型文献
Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity
文献摘要:
As a first-line treatment,radiotherapy(RT)is known to modulate the immune microenvironment of glioma,but it is unknown whether the meningeal lymphatic vessel(MLV)-cervical lymph node(CLN)network regulates the process or influences RT efficacy.Here,we show that the MLV-CLN network contributes to RT efficacy in brain tumors and mediates the RT-modulated anti-tumor immunity that is enhanced by vascular endothelial growth factor C(VEGF-C).Meningeal lymphatic dysfunction impaired tumor-derived dendritic cell(DC)trafficking and CD8+T cell activation after RT,whereas tumors overexpressing VEGF-C with meningeal lymphatic expansion were highly sensitive to RT.Mechanistically,VEGF-C-driven modulation of RT-triggered anti-tumor immunity was attributed to C-C Motif Chemokine Ligand 21(CCL21)-dependent DC trafficking and CD8+T cell activation.Notably,delivery of VEGF-C mRNA significantly enhanced RT efficacy and anti-tumor immunity in brain tumors.These findings suggest an essential role of the MLV-CLN network in RT-triggered anti-tumor immunity,and highlight the potential of VEGF-C mRNA for brain tumor therapy.
文献关键词:
作者姓名:
Changping Zhou;Lu Ma;Han Xu;Yingqing Huo;Jincai Luo
作者机构:
Laboratory of Vascular Biology,Institute of Molecular Medicine,College of Future Technology,Beijing Key Laboratory of Cardiometabolic Molecular Medicine,Peking University,Beijing,China
引用格式:
[1]Changping Zhou;Lu Ma;Han Xu;Yingqing Huo;Jincai Luo-.Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity)[J].细胞研究(英文版),2022(06):543-554
A类:
Meningeal,lymphatics
B类:
radiotherapy,efficacy,through,modulating,anti,immunity,first,line,treatment,immune,microenvironment,glioma,unknown,whether,meningeal,vessel,MLV,cervical,node,CLN,network,regulates,process,influences,Here,show,that,contributes,brain,tumors,mediates,modulated,enhanced,by,vascular,endothelial,growth,VEGF,dysfunction,impaired,derived,dendritic,cell,DC,trafficking,CD8+T,activation,after,whereas,overexpressing,expansion,were,highly,sensitive,Mechanistically,driven,modulation,triggered,was,attributed,Motif,Chemokine,Ligand,CCL21,dependent,Notably,delivery,significantly,These,findings,suggest,essential,role,highlight,potential
AB值:
0.485527
相似文献
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Perfluorooctyl bromide nanoemulsions holding MnO2 nanoparticles with dual-modality imaging and glutathione depletion enhanced HIFU-eliciting tumor immunogenic cell death
Xinping Kuai;Yuefei Zhu;Zheng Yuan;Shengyu Wang;Lin Lin;Xiaodan Ye;Yiping Lu;Yu Luo;Zhiqing Pang;Daoying Geng;Bo Yin-Department of Radiology,Huashan Hospital,Fudan University,Shanghai 200040,China;School of Pharmacy,Fudan University,Key Laboratory of Smart Drug Delivery,Ministry of Education,Shanghai 201203,China;Department of Radiology,Shanghai First Maternity and Infant Hospital,Tongji University School of Medicine,Shanghai 201204,China;Department of Radiology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 201800,China;Department of Radiology,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China;State Key Laboratory of High Performance Ceramics and Superfine Microstructure,School of Chemical Science and Engineering,Shanghai 200092,China
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignancies
Kai-long Jiang;Le-xian Tong;Tao Wang;Han-lin Wang;Xiao-bei Hu;Gao-ya Xu;Ting-ting Jin;Wei-juan Kan;Lei Xu;Jia-nan Li;Kai-xiang Zhang;Ning Song;Jie-yu Liu;Meng-meng Zhang;Wen-biao Wu;Yu-qi Xiang;An-hui Gao;Yong-zhou Hu;Yu-bo Zhou;Tao Liu;Jian-min Yang;Jia Li-National Center for Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;ZJU-ENS Joint Laboratory of Medicinal Chemistry,Zhejiang Province Key Laboratory of Anti-Cancer Drug Research,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Changhai Hospital,Naval Medical University,Shanghai 200433,China;Shanghai Tech University,Shanghai 201210,China;Zhongshan Institute for Drug Discovery,Institutes of Drug Discovery and Development,Chinese Academy of Sciences,Zhongshan 528400,China ;College of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210033,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。